Have you seen us on TV? Watch Now

Innovations in Science

We're accelerating the delivery of treatments and cures.

2023 MDA Clinical & Scientific Conference

Abstract Submissions

MDA has updated our submission guidelines for all abstracts and posters.

For those submitting an abstract who would like to be considered for oral presentations at the 2023 MDA Clinical & Scientific Conference, abstracts must be submitted on or before October 31, 2022. Anything submitted after October 31, 2022, will be submitted for poster session only.

For those submitting an abstract only as a poster submission at the 2023 MDA Clinical & Scientific Conference abstracts must be submitted on or before December 31, 2022.

2023 Late Breaking Abstract Guidelines

Late breaking abstracts for particularly high-profile projects will be considered for oral presentations via MDA’s late breaking abstract portal starting on January 18, 2023 - February 15, 2023. Submissions past this final deadline will not be accepted with no exceptions.

Late-breaking abstracts must not have been presented, accepted for presentation, or published at any other scientific meeting or journal at the time of submission and must contain data that was only made available after the December 31,2021 abstract submission deadline. Some oral presentation slots will be dedicated to late-breaking abstracts of high-impact.

MDA 2023 Embargo Policy

All abstracts accepted for the 2023 MDA Clinical & Scientific Conference will be available in the Abstract Library starting Tuesday, February 28, 2023*.

While authors may publish that their poster has been selected for inclusion in the conference program, data from the final poster presentation may not be shared in any form (print, broadcast or online publication, media release or conference presentation) prior to its official presentation at MDA Conference 2023 which will be Sunday, March 19, 2023, 6:00PM CST. Author(s) retains copyright of his or her abstract and poster.

Encores are permitted provided that: (i) copyright requirements from the initial conference are respected and (ii) prior presentations are disclosed.

Questions about the abstract submission process or poster session guidelines, please contact 2023mdaconference@mdausa.org.

Find MDA
in your Community